Showing results (1711-1720 of 1,895) with videos related to
Sort By:
Pageof 190
Journal of Medicinal Chemistry|April 3, 2019
Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor AtazanavirMurugaiah A M Subbaiah, Sandhya Mandlekar, Sridhar Desikan, et al.Neurology(R) Neuroimmunology & Neuroinflammation|April 12, 2022
Clinical utility of AQP4-IgG titers and measures of complement-mediated cell killing in NMOSDJiraporn Jitprapaikulsan, James P Fryer, Masoud Majed, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2019
Meeting report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancerM J Gunter, S Alhomoud, M Arnold, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 16, 2021
Value of systematic genetic screening of patients with amyotrophic lateral sclerosisStephanie R Shepheard, Matthew D Parker, Johnathan Cooper-Knock, et al.Journal of Neuropathology and Experimental Neurology|October 9, 2018
Sellar Region Atypical Teratoid/Rhabdoid Tumors in Adults: Clinicopathological Characterization of Five Cases and Review of the LiteratureMichael A Paolini, Benjamin R Kipp, William R Sukov, et al.The Journal of Burn Care & Rehabilitation|February 8, 2000
American Burn Association/Shriners Hospitals for Children burn outcomes questionnaire: construction and psychometric propertiesL H Daltroy, M H Liang, C B Phillips, et al.Circulation|May 23, 2001
Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosisA W Heldman, L Cheng, G M Jenkins, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 29, 2023
A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's DiseaseThomas Payne, Matthew Appleby, Ellen Buckley, et al.Nature Medicine|January 19, 2010
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growthA McGarry Houghton, Danuta M Rzymkiewicz, Hongbin Ji, et al.Journal for Immunotherapy of Cancer|February 28, 2025
T-cell immune checkpoint inhibition plus hypomethylation for locally advanced HER2-negative breast cancer: a phase 2 neoadjuvant window trial of decitabine and pembrolizumab followed by standard neoadjuvant chemotherapyHarry D Bear, Xiaoyan Deng, Dipankar Bandyopadhyay, et al.Pageof 190